Ashland University grad Rich Ferrari to give lecture

Staff report

Rich Ferrari

Rich Ferrari

ASHLAND — Ashland University alumnus Rich Ferrari will returning to the AU campus Aug. 28 to give a lecture hosted by the Burton D. Morgan Center for Entrepreneurial Studies in the Dauch College of Business and Economics.

“We are so grateful that one of our most prominent business graduates has agreed to return to campus to make a public presentation for our students and those in the community,” said Dr. Elad Granot, dean of the Dauch College.

On Tuesday, Aug. 28, at 4 p.m., Ferrari will discuss “Moments of Truth” in the Ridenour Room in the Dauch College of Business and Economics. The event is free and open to the public.

Thomas Sudow, director of AU’s Morgan Center, said that Ferrari’s presentation is the first in an overall lecture series titled “Excellent by Choice,” a series that Ferrari has been developing for a number of years.

“During this lecture, Rich will use real world examples to illustrate how even little things that happen all the time can alter your business or life in a positive or negative direction,” Sudow said. “How you handle this situation can be a make it or break it experience. How you rise above normal and average and stand out can be your moment of truth.”

While the event is free, those wishing to attend should do at:

Ferrari came to Ashland College from Long Island, N.Y., to play lacrosse during the mid-1970s and during his junior year began to develop his personal philosophy that would help guide his life. He has gone on to have a very successful career in the venture capital industry in Silicon Valley.

Ferrari is co-founder of De Novo Ventures, which has $650 million under management and is one of the premier firms dedicated to Medical Devices and Bio-Technology.

Additionally, Ferrari has been a successful CEO of two publicly traded medical technology companies. Cardiovascular Imaging Systems, the first and leading developer of ultrasound imaging catheters that was eventually acquired for $125 million by Boston Scientific. His most recent success, CardioThoracic Systems (CTS), the market leader in disposable instruments and systems for performing minimally invasive beating heart bypass surgery, was acquired by Guidant for $350 million in November 1999.

Ferrari is the recipient of the Mallinckrodt Award for Excellence in Medicine and has been a finalist for the Entrepreneur of the Year Award. He holds a Bachelor of Science degree from Ashland University and an MBA from the University of South Florida.

Rich Ferrari Ferrari

Staff report